New York State Common Retirement Fund Increases Holdings in Vericel Corporation

Summary

The New York State Common Retirement Fund increased its stake in Vericel Corporation (NASDAQ:VCEL) by 0.9% during the first quarter, now owning 862,331 shares valued at $38.48 million. Other institutional investors have also significantly increased their holdings. Vericel’s current stock price is $39.82, with a market cap of $2 billion. The company reported quarterly revenue of $52.6 million but failed to meet earnings per share expectations. Analysts have mixed ratings on the stock, with a common target price of $61.14 and an average rating of ‘moderate buy’.Market Beat Truist Financial lowered Vericel’s target price from $61.00 to $51.00 in a report dated April 11, maintaining a ‘buy’ rating. Stephens reaffirmed an ‘overweight’ rating on June 16 and set a target price of $67.00.Market Beat

Impact Analysis

This event is classified at the company level, focusing on Vericel Corporation. The New York State Common Retirement Fund’s increased holdings indicate institutional confidence in Vericel’s potential despite the company missing earnings expectations. This aligns with mixed analyst outlooks, where Truist Financial reduced its target price, reflecting caution due to unmet earnings, while Stephens maintained a bullish stance with a higher target price.Market Beat+ 2 The first-order effects include potential positive investor sentiment due to institutional backing, possibly stabilizing or boosting the stock price. Second-order effects could involve increased scrutiny on Vericel’s future earnings reports and financial performance. Investment opportunities include buying Vericel stock, considering its lower current price relative to some price targets, while weighing risks such as earnings volatility and market competition.